EICHORCondition: Advanced Solid Tumor · Sponsor: BeOne Medicines
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary antitumor activity of BG-C0979 monotherapy or in combination with tislelizumab in participants with selected advanced solid tumors. The study will consist of Phase 1a (Dose Escalation and Safety Expansion) and Phase 1b (Dose Expansion).
This description comes directly from the study's public registry record.
Study Director · 8778285568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
| Washington University School of Medicine | St Louis, Missouri, United States | Recruiting |
| John Theurer Cancer Center Hackensack University Medical Center | Hackensack, New Jersey, United States | Recruiting |
| Next Oncology San Antonio | San Antonio, Texas, United States | Recruiting |
| Northern Beaches Hospital | Frenchs Forest, New South Wales, Australia | Recruiting |
| Liverpool Hospital | Liverpool, New South Wales, Australia | Recruiting |
| Icon Cancer Centre South Brisbane | South Brisbane, Queensland, Australia | Recruiting |
| Cabrini Hospital Malvern | Malvern, Victoria, Australia | Recruiting |
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing, Beijing Municipality, China | Recruiting |
| Second Affiliated Hospital of Army Medical University (Xinqiao Hospital) | Chongqing, Chongqing Municipality, China | Recruiting |
| Mengchao Hepatobiliary Hospital of Fujian Medical University | Fuzhou, Fujian, China | Recruiting |
| Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South) | Guangzhou, Guangdong, China | Recruiting |
| Yichang Central Peoples Hospital | Yichang, Hubei, China | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07414836